Dachaigh › Luchd-obrach › APCER Life Sciences, Inc.
APCER Life Sciences, Inc.: Tuarastalan H-1B agus taic bhìosa
Chuir APCER Life Sciences, Inc. 6 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 6. Tuarastal meadhanach a chaidh a thabhann: $155,439.
A bheil APCER Life Sciences, Inc. a’ toirt taic do bhìosaichean H-1B?
Chuir APCER Life Sciences, Inc. 6 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 24 Gibl 2025. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Manager Pharmacovigilance, Client Site Operations | 3 | $151,648 |
| Senior Manager | 1 | $173,103 |
| Drug Safety Associate | 1 | $100,000 |
| Manager, Pharmacovigilance Operations | 1 | $176,537 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2024 | 5 | $151,648 |
| FY2025 | 1 | $176,537 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Molecular and Cellular Biologists3
- Medical and Health Services Managers1
- Occupational Health and Safety Specialists1
- Regulatory Affairs Specialists1
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Manager, Pharmacovigilance Operations | $176,537 Ìre IV | Jersey City, NJ | 24 Gibl 2025 | 26 Sult 2025 | Dearbhaichte |
| Manager Pharmacovigilance, Client Site Operations | $159,230 Ìre IV | Jersey City, NJ | 4 Sult 2024 | 1 Dàmh 2024 | Dearbhaichte |
| Manager Pharmacovigilance, Client Site Operations | $151,648 Ìre IV | Jersey City, NJ | 25 Ògmh 2024 | 8 Iuch 2024 | Dearbhaichte |
| Manager Pharmacovigilance, Client Site Operations | $141,727 Ìre IV | Jersey City, NJ | 5 Ògmh 2024 | 8 Iuch 2024 | Dearbhaichte, an uair sin air a tharraing air ais |
| Drug Safety Associate | $100,000 Ìre III | Jersey City, NJ | 7 Cèit 2024 | 16 Cèit 2024 | Dearbhaichte |
| Senior Manager | $173,103 Ìre III | Jersey City, NJ | 15 Gearr 2024 | 19 Cèit 2024 | Dearbhaichte |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).